Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Deadline Approaching: Apply for the Fierce AI Innovation Awards
Biotech
Parabilis’ upsized $670M IPO breaks new record for biotechs
Parabilis Medicines’ IPO has lived up to the hype—securing $670 million for the largest listing in the biotech sector’s history.
James Waldron
Jun 10, 2026 4:36am
ADA: Novo CSO says ‘jury still out’ on CagriSema v. retatrutide
Jun 10, 2026 11:10am
Could engaging the immune system improve AML outcomes?
Brought to you by
Ipsen
Sanofi halts phase 3 autoimmune trial early over lackluster data
Jun 10, 2026 4:25am
Charles River CEO shares ‘the next big transition’ in CRO space
Jun 10, 2026 1:05pm
GLP-1s may combat depression through a mood-boosting gut microbe
Jun 10, 2026 11:00am
More News
Big Pharma-backed SonoThera sounds off with $125M series B
Jun 10, 2026 10:48am
Ethyreal Bio raises $101M, joining biotechs gunning for Tepezza
Jun 10, 2026 9:35am
Fierce Biotech Fundraising Tracker '26: Ethyreal, City & more
Jun 10, 2026 9:30am
Novartis sticks 2nd deal with Orionis, this one worth up to $1.4B
Jun 10, 2026 8:21am
See more stories